Results 181 to 190 of about 600,406 (349)
Compared to untargeted therapy, the targeted nanocarrier, Angiopep‐2‐conjugated Lipid Nanoparticle (A‐LNP) loaded with TGN‐020 (TGN), selectively accumulated in stroke‐injured regions. It suppressed local aquaporin‐4 (AQP4) overexpression, thereby alleviating cerebral edema and hypoperfusion while preserving global glymphatic clearance.
Lei Jin +18 more
wiley +1 more source
Diabetes mellitus and ischemic heart disease: a case-control study
Moraes Suzana Alves de
openalex +1 more source
Clinical Strategies in Ischemic Heart Disease: New Concepts and Current Controversies
William Y. Moores
openalex +1 more source
Cell‐Free DNA‐Based Theranostics for Inflammatory Disorders
Summary on the dual potential of cfDNA as biomarkers and therapeutic targets for inflammatory disorders. Figure was created with BioRender.com. ABSTRACT Inflammatory disorders are characterized by immune‐mediated inflammatory cascades that can affect multiple organs.
Jiatong Li +7 more
wiley +1 more source
Interpretation of201Tl Myocardial Scan in Ischemic Heart Disease
Kyu Hyung Ryu +7 more
openalex +1 more source
PtRhIr/Ru SAN@M nanozymes cross the blood–brain barrier and selectively accumulate in hemorrhagic brain regions. By mimicking multiple enzyme activities, they attenuate oxidative stress, modulate microglial polarization toward an anti‐inflammatory phenotype, inhibit ferroptosis, and promote neuronal repair.
Jiebo Li +17 more
wiley +1 more source
Effects of supine ergometer exercise on central and peripheral circulation in patients with ischemic heart disease. [PDF]
Matsumoto N +5 more
europepmc +1 more source

